Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Mural Oncology PLC - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
MURA
Nasdaq
8731
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Mural Oncology PLC
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 24th, 2024 8:00 pm
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
- Apr 9th, 2024 8:00 pm
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Apr 4th, 2024 8:00 pm
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Mar 26th, 2024 11:00 am
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mar 5th, 2024 9:35 pm
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 27th, 2024 12:00 pm
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
- Jan 8th, 2024 12:00 pm
Scroll